NENCI, Italo
 Distribuzione geografica
Continente #
NA - Nord America 5.454
AS - Asia 2.997
EU - Europa 2.421
SA - Sud America 539
AF - Africa 74
Continente sconosciuto - Info sul continente non disponibili 51
OC - Oceania 2
Totale 11.538
Nazione #
US - Stati Uniti d'America 5.293
SG - Singapore 1.148
IT - Italia 910
CN - Cina 777
BR - Brasile 417
DE - Germania 370
VN - Vietnam 301
UA - Ucraina 296
HK - Hong Kong 218
GB - Regno Unito 200
TR - Turchia 193
FI - Finlandia 122
FR - Francia 118
SE - Svezia 104
CA - Canada 86
RU - Federazione Russa 76
IN - India 73
BD - Bangladesh 65
JP - Giappone 59
MX - Messico 57
NL - Olanda 53
BE - Belgio 41
PL - Polonia 41
AR - Argentina 36
ID - Indonesia 30
ZA - Sudafrica 30
ES - Italia 24
EC - Ecuador 23
IQ - Iraq 23
PK - Pakistan 21
VE - Venezuela 16
CL - Cile 14
AT - Austria 12
CZ - Repubblica Ceca 12
CO - Colombia 11
UZ - Uzbekistan 11
MA - Marocco 10
PH - Filippine 10
AE - Emirati Arabi Uniti 8
CH - Svizzera 7
KE - Kenya 7
PY - Paraguay 7
SA - Arabia Saudita 7
TN - Tunisia 7
AL - Albania 6
AZ - Azerbaigian 6
IR - Iran 6
MY - Malesia 6
PE - Perù 6
RO - Romania 6
AO - Angola 5
BO - Bolivia 5
LT - Lituania 5
EG - Egitto 4
IL - Israele 4
JO - Giordania 4
KZ - Kazakistan 4
OM - Oman 4
SV - El Salvador 4
CR - Costa Rica 3
HR - Croazia 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
AU - Australia 2
BH - Bahrain 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
IE - Irlanda 2
JM - Giamaica 2
KR - Corea 2
LY - Libia 2
NP - Nepal 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LV - Lettonia 1
ME - Montenegro 1
MG - Madagascar 1
MN - Mongolia 1
MU - Mauritius 1
MZ - Mozambico 1
NI - Nicaragua 1
PS - Palestinian Territory 1
Totale 11.484
Città #
Singapore 744
Ashburn 564
San Jose 446
Woodbridge 367
Chandler 321
Jacksonville 296
Ann Arbor 274
Santa Clara 272
Fairfield 263
Beijing 233
Hong Kong 215
Houston 214
New York 150
Wilmington 116
Izmir 112
Los Angeles 107
Seattle 107
Dallas 99
Ho Chi Minh City 94
Cambridge 89
Munich 84
Nanjing 84
Hanoi 81
Princeton 62
Bremen 60
Milan 60
Tokyo 58
Buffalo 56
Lauterbourg 49
Dearborn 47
Rome 47
Shanghai 46
São Paulo 46
Council Bluffs 45
Brussels 40
Brooklyn 37
Mexico City 37
Helsinki 36
Nanchang 34
Hefei 33
Turku 31
Warsaw 31
Boardman 30
Ferrara 30
San Diego 30
Orem 29
Hebei 28
Tianjin 28
Toronto 26
Montreal 25
Chennai 23
Denver 23
Atlanta 22
London 22
Shenyang 22
Johannesburg 21
Manchester 20
San Mateo 18
Stockholm 18
San Francisco 17
Changsha 16
Chicago 16
Frankfurt am Main 16
Jakarta 16
Amsterdam 15
Auburn Hills 15
Bologna 15
Falls Church 15
Rio de Janeiro 15
Poplar 14
Zhengzhou 14
Baghdad 13
Belo Horizonte 13
Boston 13
Haiphong 13
Jinan 13
Palermo 13
Ankara 12
Brasília 12
Da Nang 12
Falkenstein 12
Jiaxing 12
Querétaro 11
Tashkent 11
Guangzhou 10
Moscow 10
Mumbai 10
Bari 9
Kunming 9
Naples 9
Napoli 9
Phoenix 9
Brno 8
Campinas 8
Florence 8
Guayaquil 8
Lahore 8
Nuremberg 8
Ottawa 8
Philadelphia 8
Totale 7.085
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 664
Integrazione del Nottingham Prognostic Index con i fenotipi biologici per una migliore definizione prognostica delle pazienti affette da carcinoma della mammella. 565
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 261
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 260
Valutazione biologica multiparametrica di 5284 carcinomi mammari infiltranti (1990-2005): il ruolo del patologo nelle scelte terapeutiche 234
Valutazione dell'espressione di GATA3 con tecnica del tissue microarray (TMA) e significato prognostico nel carcinoma mammario infiltrante 229
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts 218
Commentary on human mammary neoplasia. The Estrogen Receptor-promotion hypothesis 210
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 208
Aneurysmal fibrous histiocytoma: Case report and review of the literature 204
Espressione dei MicroRNA nei carcinomi mammari 201
The 70 Gene Mammaprint signature: Ferrara's experience 196
Italy, Ferrara province 194
Il problema dei tumori in provincia di Ferrara: incidenza, mortalità e prospettive terapeutiche 193
Quantitative immunoprofiles of breast cancer performed by image analysis 192
Registro Tumori della provincia di Ferrara 191
Contribution of cell kinetics with Ki-67 to the biopathological and prognostic characterization of breast cancer 190
Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression 188
BRCA1 LOH and biological profile of breast cancer. Comparison between two age groups. 188
Biological profile of breast carcinoma in situ investigated by immunohistochemical technique 187
Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology 183
Loss of methylation at chromosome 11p15.5 is common in human adult tumors 183
Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodies 183
Axillary lymph node nanometastases are prognostic factors for metastatic relapse 182
Diagnosi citologica molecolare integrata (reflex test) nella patologia neoplastica dell'urotelio. 179
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 178
The 70 gene Mammaprint signature: a comparison with traditional clinico-pathological parameters. 177
High incidence of ependymomas induced by BK virus, a human papovavirus: brief communication. 172
Cancer Incidence in Ferrara Province (1998-2002) 172
Indicatori e valori di riferimento nella valutazione della ploidia del carcinoma mammario 168
Comparison of cytology test in patients under surveillance after transurethral resection of superficial urothelial carcinoma 168
Quantitative analysis of molecular markers MCM2, TOPO2A and KI-67 (Mib1) in squamous intraepithelial neoplasia in liquid-based cytology 167
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 167
Immunocytochemical Demonstration of Estrogen Receptors by Monoclonal antibodies in Human breast cancer: Correlation with estrogen receptor assay by Dextran-coated Charcoal Method 167
Expression of p21 ras gene products in breast cancer relates to histological types and to receptor nodal status 166
The 70 gene Mammaprint Signature: a comparison with traditional clinco-pathological tools. 165
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer 163
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women 158
Biological staging of incipient, in situ and invasive breast carcinomas 156
p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features 156
Interobserver reproducibility of immunohistochemical HER-2/neu assessment in human breast cancer: An update from INQAT round III 155
Quality control for biomarker determination in oncology: The experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT) 154
Urovysion(TM) test: confronto tra citologia convenzionale e citologia molecolare nel follow-up di pazienti affetti da patologia neoplastica dell'urotelio 153
Markers of DNA-replication licensing systems in cervical dysplasia 149
Sentinel node and bone marrow micro metastases and nanometastases 144
Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGRbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes 130
Italy, Ferrara province 130
The 70-Gene Mammaprint Signature for risk stratification in breast cancer: a comparison with traditional pathological and clinical tools 125
Assessment of Proliferative rate of breast cancer by Ki-67 Monoclonal Antibody 125
Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters 120
Linkage of biopsy, cancer, and population records aimed at the estimation of family risks in neoplasia: A pilot study 120
MESECTODERMAL LEIOMYOMA EXCLUSIVELY INVOLVING THE POSTERIOR CHOROID. 119
Italy, Ferrara 118
MicroRNA gene expression deregulation in human breast cancer 117
Italy, Ferrara Province 112
90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells 112
I Tissue micro arrays come strumento di ricerca e loro possibile utilizzo nella pratica clinica routinaria 111
null 107
Suppression of tumorigenesis by the breast cancer cell line MCF-7 following transfer of a normal human chromosome 11 104
Immunohistochemistry expression of c-erbB-2 in human breast cancer by monoclonal antibody: Correlation with lymph node and ER status 103
null 98
null 93
null 86
null 85
Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods 76
null 75
null 64
Monoclonal Antibodies for Specific Immunoperoxidase Detection of Campylobacter pylori 38
null 32
Totale 11.538
Categoria #
all - tutte 46.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.558
Totale 50.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022685 18 74 32 60 65 19 18 48 23 46 60 222
2022/2023775 60 70 31 94 163 109 28 57 81 11 39 32
2023/2024409 44 24 32 16 24 101 17 40 8 9 19 75
2024/20251.696 59 37 113 48 211 190 56 92 268 178 237 207
2025/20264.457 437 151 389 594 690 314 522 198 430 484 181 67
2026/2027126 126 0 0 0 0 0 0 0 0 0 0 0
Totale 11.538